246 related articles for article (PubMed ID: 35342344)
1. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity.
Peng S; Li Y; Huang M; Tang G; Xie Y; Chen D; Hu Y; Yu T; Cai J; Yuan Z; Wang H; Wang H; Luo Y; Liu X
Int J Biol Sci; 2022; 18(5):1912-1932. PubMed ID: 35342344
[TBL] [Abstract][Full Text] [Related]
2. Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
Peng S; Chen D; Cai J; Yuan Z; Huang B; Li Y; Wang H; Luo Q; Kuang Y; Liang W; Liu Z; Wang Q; Cui Y; Wang H; Liu X
Mol Oncol; 2021 May; 15(5):1391-1411. PubMed ID: 33528867
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells.
Gong J; Lin Y; Zhang H; Liu C; Cheng Z; Yang X; Zhang J; Xiao Y; Sang N; Qian X; Wang L; Cen X; Du X; Zhao Y
Cell Death Dis; 2020 Apr; 11(4):267. PubMed ID: 32327627
[TBL] [Abstract][Full Text] [Related]
4. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
5. Elucidating tumor-stromal metabolic crosstalk in colorectal cancer through integration of constraint-based models and LC-MS metabolomics.
Wang J; Delfarah A; Gelbach PE; Fong E; Macklin P; Mumenthaler SM; Graham NA; Finley SD
Metab Eng; 2022 Jan; 69():175-187. PubMed ID: 34838998
[TBL] [Abstract][Full Text] [Related]
6. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
7. Bufalin reverses cancer-associated fibroblast-mediated colorectal cancer metastasis by inhibiting the STAT3 signaling pathway.
Wang H; Chen J; Li S; Yang J; Tang D; Wu W; Yu K; Cao Y; Xu K; Yin P; Chen Y; Li W
Apoptosis; 2023 Apr; 28(3-4):594-606. PubMed ID: 36705874
[TBL] [Abstract][Full Text] [Related]
8. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.
Landskron G; De la Fuente López M; Dubois-Camacho K; Díaz-Jiménez D; Orellana-Serradell O; Romero D; Sepúlveda SA; Salazar C; Parada-Venegas D; Quera R; Simian D; González MJ; López-Köstner F; Kronberg U; Abedrapo M; Gallegos I; Contreras HR; Peña C; Díaz-Araya G; Roa JC; Hermoso MA
Front Immunol; 2019; 10():1394. PubMed ID: 31281317
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B.
Zhu HF; Zhang XH; Gu CS; Zhong Y; Long T; Ma YD; Hu ZY; Li ZG; Wang XY
Cancer Biol Ther; 2019; 20(7):967-978. PubMed ID: 30894065
[TBL] [Abstract][Full Text] [Related]
12. PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.
Lai SW; Cheng YC; Kiu KT; Yen MH; Chen YW; Yadav VK; Yeh CT; Kuo KT; Chang TC
Aging (Albany NY); 2024 Jan; 16(2):1620-1639. PubMed ID: 38244581
[TBL] [Abstract][Full Text] [Related]
13. miR-1246 shuttling from fibroblasts promotes colorectal cancer cell migration.
Si G; Li S; Zheng Q; Zhu S; Zhou C
Neoplasma; 2021 Mar; 68(2):317-324. PubMed ID: 33231089
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9.
Ao T; Mochizuki S; Kajiwara Y; Yonemura K; Shiraishi T; Nagata K; Shinto E; Okamoto K; Nearchou IP; Shimazaki H; Kishi Y; Okada Y; Ueno H
Int J Cancer; 2022 May; 150(10):1706-1721. PubMed ID: 35080810
[TBL] [Abstract][Full Text] [Related]
15. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
[No Abstract] [Full Text] [Related]
16. TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer.
Izumi D; Toden S; Ureta E; Ishimoto T; Baba H; Goel A
Cell Death Dis; 2019 Mar; 10(4):267. PubMed ID: 30890693
[TBL] [Abstract][Full Text] [Related]
17. YAP, a novel target regulates F-actin rearrangement-associated CAFs transformation and promotes colorectal cancer cell progression.
Naktubtim C; Payuhakrit W; Uttarawichien T; Hassametto A; Suwannalert P
Biomed Pharmacother; 2022 Nov; 155():113757. PubMed ID: 36271545
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses.
Wang Y; Chen Z; Zhao G; Li Q
Mediators Inflamm; 2023; 2023():3781091. PubMed ID: 37144239
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression.
Hsu WH; LaBella KA; Lin Y; Xu P; Lee R; Hsieh CE; Yang L; Zhou A; Blecher JM; Wu CJ; Lin K; Shang X; Jiang S; Spring DJ; Xia Y; Chen P; Shen JP; Kopetz S; DePinho RA
Cancer Discov; 2023 Dec; 13(12):2652-2673. PubMed ID: 37768068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
